global Artificial Insemination market size is expected to be worth around US$ 2.11 billion by 2028, according to a new report by Vision Research Reports.
The global Artificial Insemination market size was valued at US$ 1.10 billion in 2020 and is anticipated to grow at a CAGR of 8.10% during forecast period 2021 to 2028.
Growth Factors
Over the past few years, infertility has become a major public health concern across the globe. Artificial insemination is usually the preferred first-line treatment to tackle infertility. Lifestyle changes, delay in pregnancy, and hormonal issues are some of the reasons contributing to the rise in fertility-related problems. According to the United Nations, the global fertility rate is expected to decline to 2.2% by 2050. In developing or underdeveloped nations, medical consultation regarding infertility was not easily accessible.
Hence, there was a lack of awareness about available assisted reproductive techniques including artificial or donor insemination and IVF. The average cost of performing an IUI is around USD 865. The success rate for each cycle is around 4 to 5%, which can be increased to about 7 to 16% by consuming fertility drugs. However, older women are not encouraged to go through IUI due to slim chances of success and further complications. Several fertility problems can be addressed through IUI, such as semen allergy, unexplained infertility, and Sexually Transmitted Diseases (STDs).
Report Highlights
Intrauterine insemination held the majority of the market share in 2020 and is likely to retain its position. It is expected to be the fastest-growing segment over the forecast period. This mode of insemination is most preferred for infertility treatment as it provides the highest pregnancy rate. Also, it is a non-invasive technique. Intravaginal (IVI) is projected to be the second-largest segment. IVI can be performed at fertility clinics or home and is especially preferred in cases of surrogacy and donor insemination.
Fertility clinics held the largest market share in 2020 and are likely to be the fastest-growing end-use segment over the forecast period. The number of medical centers offering infertility treatment has increased over the past few years due to rising infertility rates across the world. All the types of artificial insemination procedures can be performed at fertility clinics.
Mostly, Intrauterine (IUI) and Intratubal (ITI) procedures are performed in fertility clinics. Insemination procedures at clinics involve consultation, which includes determination of the ovulation cycle before initiating the procedures. Also, doctors can prescribe fertility medications to increase the chances of conception.
Artificial Insemination by Husband (AIH) segment led the market. It is also expected to witness the fastest CAGR over the forecast period. Donor insemination (AID) opts as a last alternative by couples with non-viable sperm. Single women or same-sex couples can also choose AID. Donor insemination has proven to be safe as sperm banks are supposed to provide personal medical and extensive family histories of donors.
Europe was the largest regional market in 2020 as the fertility rate in the region has been decreasing over the years. Delay in pregnancy and lifestyle changes are among the factors contributing to this decline. North America was the second-largest market. There were only 62.5 births per 1000 women, according to the National Center for Health Statistics. The Asia Pacific is expected to be the fastest-growing market in the forecast years due to the increasing infertility rate and raising awareness about the available treatment options.
Key Players
Vitrolife; Genea Limited; Rinovum Women’s Health, LLC; Pride Angel; Hi-Tech Solutions; FUJIFILM Irvine Scientific; KITAZATO CORPORATION; Rocket Medical plc.
Market Segmentation
Type Outlook
IntrauterineIntracervical
Intravaginal
Intratubal
End-Use Outlook
Fertility Clinics & Other Facilities
Home
Source Type Outlook
AIH-Husband
AID-Donor
Regional Outlook
North America
The U.S.
Canada
Europe
U.K.
Germany
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
The Artificial Insemination market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Artificial Insemination market for the base year 2020 and the forecast between 2021 and 2028. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Artificial Insemination market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Artificial Insemination market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Artificial Insemination market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Artificial Insemination capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Artificial Insemination by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Artificial Insemination market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2028. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Artificial Insemination market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Artificial Insemination market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Artificial Insemination industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Artificial Insemination market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Artificial Insemination market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Artificial Insemination market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Artificial Insemination market. These factors have benefited the growth of the global market for Artificial Insemination. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Artificial Insemination. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Artificial Insemination are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Artificial Insemination Market, By Type
7.1. Artificial Insemination Market, By Type, 2021-2028
7.1.1. Intracervical
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Intravaginal
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Intratubal
7.1.3.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Artificial Insemination Market, By End-Use
8.1. Artificial Insemination Market, By End-Use, 2021-2028
8.1.1. Fertility Clinics & Other Facilities
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Home
8.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Artificial Insemination Market, By Source Type
9.1. Artificial Insemination Market, By Source Type, 2021-2028
9.1.1. AIH-Husband
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. AID-Donor
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Artificial Insemination Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.1.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.1.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.1.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.2.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.2.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.2.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.2.6.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.7.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.2.7.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.3.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.3.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.3.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.3.6.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.7.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.3.7.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.4.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.4.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.6.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.4.6.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.7.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.4.7.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.4.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.5.4.3. Market Revenue and Forecast, By Source Type (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.5.2. Market Revenue and Forecast, By End-Use (2016-2028)
10.5.5.3. Market Revenue and Forecast, By Source Type (2016-2028)
Chapter 11. Company Profiles
11.1. Vitrolife
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Genea Limited
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Rinovum Women’s Health, LLC
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Pride Angel
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. Hi-Tech Solutions
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. FUJIFILM Irvine Scientific
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. KITAZATO CORPORATION
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Rocket Medical plc
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. Hill Dermaceuticals, Inc.
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Mylan N.V.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms